Needham, MA, United States of America

Yongxin Han

USPTO Granted Patents = 63 

 

Average Co-Inventor Count = 6.5

ph-index = 6

Forward Citations = 238(Granted Patents)

Forward Citations (Not Self Cited) = 234(Oct 12, 2025)


Inventors with similar research interests:


Location History:

  • Quebec, CA (2000)
  • Kirland, CA (2012)
  • Montreal, CA (2015)
  • Kirkland, CA (1997 - 2016)
  • Shanghai, CN (2016)
  • Needham, MA (US) (2016 - 2024)

Company Filing History:


Years Active: 1997-2025

Loading Chart...
Loading Chart...
63 patents (USPTO):

Title: Innovations and Contributions of Yongxin Han

Introduction

Yongxin Han, based in Needham, MA, has made significant strides in the field of pharmaceutical innovations, holding an impressive total of 62 patents. His work in this domain has contributed to the advancement of therapies that address various diseases and disorders.

Latest Patents

Among his latest patents is the development of substituted tetrahydroquinolin compounds identified as indoleamine 2,3-dioxygenase (IDO) inhibitors. This innovative work offers potential treatments for IDO-associated diseases or disorders, highlighting the therapeutic applications of these compounds in medicinal formulations. Additionally, he has patented aryl sulfonamides as antagonists of the leukotriene B receptor 1 (BLT1). These novel compounds are poised to be instrumental in combating a range of health issues, including Type 2 diabetes, obesity, and various metabolic disorders.

Career Highlights

Yongxin Han has worked with prominent pharmaceutical companies such as Merck Sharp & Dohme Corporation and Merck & Company, Inc. His contributions to these organizations reflect his expertise in drug discovery and development, particularly in areas affecting human health.

Collaborations

Throughout his career, Yongxin has collaborated with esteemed colleagues, including Xavier Fradera and Hongjun Zhang. These partnerships have fostered a collaborative environment that facilitates the exchange of ideas and enhances research outcomes.

Conclusion

Yongxin Han's innovative work and his extensive patent portfolio underline his critical role in the pharmaceutical industry. His ongoing research and collaborations signify a commitment to addressing significant health challenges, making substantial contributions toward medical advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…